First Turn Management »

Fulcrum Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $21M 1.9M 11.31

More positions owned by First Turn Management

Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Insmed Com Par $.01 (INSM)
Bridgebio Pharma (BBIO)
Mirum Pharmaceuticals (MIRM)
Axsome Therapeutics (AXSM)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Terns Pharmaceuticals (TERN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for First Turn Management

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Braidwell
Adage Capital Partners GP
Point72 Asset Management
Siren
First Turn Management
Balyasny Asset Management
D. E. Shaw & Co
Ikarian Capital
ADAR1 Capital Management

View all funds holding Fulcrum Therapeutics